Treatment Investigations

In an effort to determine why treatments are successful for some multiple sclerosis patients but not all, researchers have identified certain types of inflammatory responses in lab animals and are investigating different agents to determine the best treatments based on cause of the inflammation.

Posted in news | Leave a comment

Reprogramming Stem Cells

Scientists working  with adult stem cells in laboratory animals have developed a technique that allows them to influence the fate of cells within the natural brain environment.

Posted in news | Leave a comment

MS Pill Enters Phase 3 Testing

Laqininimod, a pill from Teva Pharmaceuticals has shown enough promise and safety in the treatment of relapsing remitting multiple sclerosis that the manufacturer is now preparing the product for a phase 3 study. No oral disease modifying therapy has made it past this phase in the drug trial stages, although a “cousin” of Laquinimod did survive until phase 3 when the drug was discovered to have adverse effects on the heart.

Posted in news | Leave a comment

Tech Tools and Tips

Microsoft has a column with tips for persons with multiple sclerosis that can enable them to use Microsoft Office products more effectively.

MyMSmyWay has links to freeware and other suggestions for making life with you computer more productive.

Posted in news | Leave a comment

Prozac Limits Lesions

A small double blind study of Prozac therapy for multiple sclerosis has concluded with a reduction of  neurological inflammation for the group recieving the active medication. The results suggest further study. 

Posted in news | Leave a comment

A Pill a Day – Keeps the Attacks Away

Studies have shown that the Novartis compound called FT720 has shown a high effectiveness for stopping exacerbations for up to 75 % of multiple sclerosis patients  after three years in an extended clinical trial. The medicine is a once a day pill that would be a more palatable alternative to the injectable therapies that are commonplace for treating MS presently.

Posted in news | Leave a comment

Rituxin Disappoints

There were hopes that the drug Rituxin might benefit multiple sclerosis patients with the primary progressive stage of the disease,  but a long term study of the therapy failed to produce a significant benefit.

Posted in news | Leave a comment

Your Opionion Matters

The firm devoloping brochures and informational materials for a multiple sclerosis clinical trial wants your thoughts on design and suggestions on content. If you are interested please visit the post in the forum by clicking here.

Posted in news | Leave a comment

T- Cell Booster

A new drug that has been proven effective against auto immune disease in mice is now being studied in humans with multiple sclerosis  to determine if the same positive results can be achieved.

Posted in news | Leave a comment

Testing Heat Sensitivity

UT Southwestern scientists are using a special suit that delivers heating or coooling to MS patients and then observing the resulting effects on vision, The results may help develop and determine therapies for heat related symptoms in multiple sclerosis.

Posted in news | Leave a comment